Study: NCT01700946

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cyclophosphamide
Description: given intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: etoposide
Description: given intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: etoposide
Description: given intravenously

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: aldesleukin
Description: given subcutaneously

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: aldesleukin
Description: given subcutaneously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pegaspargase
Description: given intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pegaspargase
Description: given intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methotrexate
Description: given intrathecally or intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methotrexate
Description: given intrathecally or intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mercaptopurine
Description: given orally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mercaptopurine
Description: given orally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cytarabine
Description: given intrathecally or intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cytarabine
Description: given intrathecally or intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mitoxantrone
Description: given intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mitoxantrone
Description: given intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: teniposide
Description: given intravenously

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: vinblastine
Description: given intravenously

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: natural killer cell infusion
Description: undergo allogeneic natural killer cell infusion

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: natural killer cell infusion
Description: undergo allogeneic natural killer cell infusion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: laboratory biomarker analysis
Description: correlative studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: laboratory biomarker analysis
Description: correlative studies

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: therapeutic hydrocortisone
Description: given intrathecally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: therapeutic hydrocortisone
Description: given intrathecally

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: allogeneic hematopoietic stem cell transplantation
Description: undergo allogeneic HSCT

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CliniMACS
Description: The mechanism of action of the CliniMACS Cell Selection System is based on magnetic-activated cell sorting (MACS). The CliniMACS device is a powerful tool for the isolation of many cell types from heterogeneous cell mixtures, (e.g. apheresis products). These can then be separated in a magnetic field using an immunomagnetic label specific for the cell type of interest, such as CD3+ human T cells.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CliniMACS
Description: The mechanism of action of the CliniMACS Cell Selection System is based on magnetic-activated cell sorting (MACS). The CliniMACS device is a powerful tool for the isolation of many cell types from heterogeneous cell mixtures, (e.g. apheresis products). These can then be separated in a magnetic field using an immunomagnetic label specific for the cell type of interest, such as CD3+ human T cells.